WA
CORT icon

WPG Advisers’s Corcept Therapeutics CORT Stock Holding History

WPG Advisers’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.22K Hold
37
– – ﹤0.01% 1079
2026
Q1 		$1.49K Sell
37
-132
-78% -$4.94K ﹤0.01% 1160
2025
Q4 		$5.88K Hold
169
– – ﹤0.01% 861
2025
Q3 		$14K Hold
169
– – 0.01% 602
2025
Q2 		$12.4K Sell
169
-12
-7% -$870 0.01% 606
2025
Q1 		$20.7K Buy
181
+10
+6% +$609 0.02% 464
2024
Q4 		$8.62K Buy
+171
New +$8.96K 0.01% 676

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

WPG Advisers's CORT Position: Q2 2026 in Review

WPG Advisers held its Corcept Therapeutics (CORT) position steady in Q2 2026 at 37 shares worth $3.22K. The position accounts for ﹤0.01% of the portfolio, ranked #1079.

WPG Advisers first reported a position in CORT in Q4 2024 and has held it in 7 quarters since. The position peaked at $20.7K in Q1 2025. 188 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • WPG Advisers held 37 shares of Corcept Therapeutics worth $3.22K as of Q2 2026.
  • WPG Advisers left its Corcept Therapeutics share count unchanged in Q2 2026.
  • Corcept Therapeutics made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #1079 holding.
  • WPG Advisers first reported a position in Corcept Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Corcept Therapeutics position peaked at $20.7K in Q1 2025.
  • 188 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.